Legislation
- Title
- Maryland Department of Health and Prescription Drug Affordability Board - Managed Care Organizations and Prescription Drug Claims - Study
- Sponsored by
- Delegates Kipke, Alston, Bagnall, Bhandari, Chisholm, Cullison, Guzzone, Hill, Hutchinson, S. Johnson, Kaiser, Kerr, R. Lewis, Lopez, Martinez, M. Morgan, Pena-Melnyk, Reilly, Rosenberg, Szeliga, Taveras, White, and Woods
- Status
- Approved by the Governor - Chapter 217
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Requiring the Maryland Department of Health and the Prescription Drug Affordability Board jointly to study certain information regarding the payment of prescription drug claims under the Maryland Medical Assistance Program during calendar years 2021 and 2022 and how to address certain inconsistencies; and requiring the Department and the Board to report the findings of the study to the Maryland Medicaid Administration and certain committees of the General Assembly by October 31, 2023.
Committees
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Last Updated: 6/9/2023 2:29 PM